- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00717041
Epidemiology of Depression, Anxiety, and Cognitive Impairment
Epidemiology of Depression, Anxiety, and Cognitive Impairment Among Emergency Department Patients
Many older adults have undetected health problems and lack basic prevention measures. Failure to identify and treat these conditions can lead to unnecessary morbidity and mortality and a decreased quality of life. Traditional screening and intervention programs, usually based in primary care providers' offices, have been insufficient, particularly in medically underserved populations. Alternate sites for screening and intervention have begun to receive attention and may hold promise.
The emergency department (ED) is the entry point for access to medical and social services for many patients and has the potential to serve as a site to identify older adults with unmet needs. However, we do not know the prevalence of depression and cognitive impairment and how they differ by mode of arrival of the patient to the ED. Second, a question remains as to the validity of screening patients during an acute illness. Upon completion, this study will describe the epidemiology of the population of older adults presenting to the ED.
Study Overview
Status
Conditions
Detailed Description
Many older adults have undetected health problems and lack basic prevention measures. Failure to identify and treat these conditions can lead to unnecessary morbidity and mortality and a decreased quality of life. Traditional screening and intervention programs, usually based in primary care providers' offices, have been insufficient, particularly in medically underserved populations. Alternate sites for screening and intervention have begun to receive attention and may hold promise.
The emergency department (ED) is the entry point for access to medical and social services for many patients and has the potential to serve as a site to identify older adults with unmet needs. However, we do not know the prevalence of depression and cognitive impairment and how they differ by mode of arrival of the patient to the ED. Second, a question remains as to the validity of screening patients during an acute illness. This study aims to:
- Compare the prevalence of depression and cognitive impairment among patients who arrive at the ED by EMS, as compared to those arriving via other means.
- Evaluate the reliability of screening patients for depression and cognitive impairment during an acute illness and after the illness.
- To evaluate correlates of depression, anxiety and suicidal ideation. Upon completion, this study will describe the epidemiology of the population of older adults presenting to the ED.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
New York
-
Rochester, New York, United States, 14646
- University of Rochester
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 60 and older
- Arrival at ED
Exclusion Criteria:
- Institutionalized
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Presenting to the ED
Patients who present to the ED
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participants With Depression by Patient Health Questionnaire - 9
Time Frame: 2 hours
|
Number of participants with depression as measured by the Patient Health Questionnaire - 9, with a score of greater than or equal to 10.
|
2 hours
|
|
Participants With Cognitive Impairment by Six Item Screener
Time Frame: 2 hours
|
Number of participants with cogintiive impairment as measured by the Six Item Screener, with greater than 2 questions incorrect
|
2 hours
|
|
Participants With Anxiety by Generalized Anxiety Disorder - 7
Time Frame: 2 hours
|
Participants with anxiety as measured by the Generalized Anxiety Disorder - 7, with a score greater than or equal to 10.
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression and Cognitive Impairment at 2 Weeks
Time Frame: 2 weeks
|
For the individuals who are able to be contacted in 2 weeks, how many still test positive for depression and cognitive impairment.
|
2 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Manish N. Shah, MD MPH, University of Rochester
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RSRB 24085
- NIH 5K23AG028942
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.